Evidence map›Paper›PMID 41041455›Full record

ArticleFrontiers in medicine2025

Molecular signatures of alveolar type II cell differentiation in acute respiratory distress syndrome.

Yu Zhang, Yazhe Wang, Chunsheng Wen, Haixu Wang, Liping Wang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu Zhang *The Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Yazhe Wang *The Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Chunsheng WenThe Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Haixu WangThe Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Liping WangThe Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition with high morbidity and mortality. Methods: We analyzed publicly available single-cell transcriptomic and microarray datasets from murine ARDS models to characterize AT2 cell differentiation trajectories following lipopolysaccharide (LPS)-induced injury. Computational mapping of cell "trajectories" revealed distinct gene expression signatures associated with divergent repair outcomes. These findings were validated in bronchoalveolar lavage fluid (BALF) samples from ARDS patients and in an LPS-induced AT2-fibroblast co-culture model. Gene expression changes were examined at both the RNA and protein levels, and pathway enrichment analysis was used to explore underlying mechanisms. Results: Trajectory analysis revealed two major differentiation branches of AT2 cells: one enriched for fibrotic programs (Igfbp6, Gstm1, Mgp, and Lgals1) and the other linked to epithelial repair (Tgm2, Anxa1, Ankrd1, and F3). Both branches exhibited distinct gene expression patterns in patient BALF, which was consistent with scRNA-seq findings. Functional enrichment highlighted the Wnt signaling pathway as a key regulator in the injury group, which was validated at protein levels Conclusion: This study highlights the important role of AT2 cell differentiation in shaping disease progression in ARDS and identifies potential molecular markers and signaling pathways involved in divergent repair outcomes. Our findings provide new insight into AT2 cell-driven lung repair and potential therapeutic targets.

Indexed as

acute respiratory distress syndromecell differentiationmarker genestrajectory analysistype II alveolar epithelial cells

Identifiers

PMID41041455
PMCPMC12483913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.